MCID: CYT005
MIFTS: 37

Cytomegalovirus Retinitis

Categories: Eye diseases, Rare diseases

Aliases & Classifications for Cytomegalovirus Retinitis

MalaCards integrated aliases for Cytomegalovirus Retinitis:

Name: Cytomegalovirus Retinitis 12 54 45 15 17 74
Cmv Retinitis 12 56

Classifications:

MalaCards categories:
Global: Rare diseases
Anatomical: Eye diseases


External Ids:

Disease Ontology 12 DOID:0080160
MeSH 45 D017726
UMLS 74 C0206178

Summaries for Cytomegalovirus Retinitis

Disease Ontology : 12 A retinitis that has material basis in Cytomegalovirus.

MalaCards based summary : Cytomegalovirus Retinitis, also known as cmv retinitis, is related to retinitis and acquired immunodeficiency syndrome. An important gene associated with Cytomegalovirus Retinitis is IL10RA (Interleukin 10 Receptor Subunit Alpha). The drugs Ganciclovir and Cidofovir have been mentioned in the context of this disorder. Affiliated tissues include eye, retina and t cells.

Wikipedia : 77 Cytomegalovirus retinitis, also known as CMV retinitis, is an inflammation of the retina of the eye that... more...

Related Diseases for Cytomegalovirus Retinitis

Diseases related to Cytomegalovirus Retinitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 82)
# Related Disease Score Top Affiliating Genes
1 retinitis 11.2
2 acquired immunodeficiency syndrome 10.7
3 retinal detachment 10.5
4 uveitis 10.4
5 leukemia 10.3
6 lymphoma 10.2
7 macular dystrophy, dominant cystoid 10.2
8 macular retinal edema 10.2
9 lymphocytic leukemia 10.2
10 leukemia, acute lymphoblastic 10.1
11 retinal vein occlusion 10.1
12 good syndrome 10.1
13 systemic lupus erythematosus 10.1
14 hematopoietic stem cell transplantation 10.1
15 neuritis 10.1
16 central retinal vein occlusion 10.1
17 human immunodeficiency virus infectious disease 10.1
18 lupus erythematosus 10.1
19 optic neuritis 10.0
20 endophthalmitis 10.0
21 encephalitis 10.0
22 retinal vascular disease 10.0
23 rheumatoid arthritis 10.0
24 arthritis 10.0
25 congenital cytomegalovirus 10.0
26 leukemia, acute myeloid 9.9
27 human immunodeficiency virus type 1 9.9
28 cataract 9.9
29 common variable immunodeficiency 9.9
30 intraocular lymphoma 9.9
31 dyskeratosis congenita 9.9
32 herpes simplex 9.9
33 lymphosarcoma 9.9
34 myeloid leukemia 9.9
35 anterior uveitis 9.9
36 cytomegalovirus infection 9.9
37 colitis 9.8
38 sarcoma 9.8
39 dementia 9.8
40 branch retinal artery occlusion 9.8
41 retinal artery occlusion 9.8
42 diabetes insipidus, nephrogenic, autosomal 9.7
43 macular dystrophy, concentric annular 9.7
44 immune deficiency disease 9.7
45 myeloma, multiple 9.7
46 immunodysregulation, polyendocrinopathy, and enteropathy, x-linked 9.7
47 hemophilia b 9.7
48 macular degeneration, age-related, 1 9.7
49 aplastic anemia 9.7
50 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 9.7

Graphical network of the top 20 diseases related to Cytomegalovirus Retinitis:



Diseases related to Cytomegalovirus Retinitis

Symptoms & Phenotypes for Cytomegalovirus Retinitis

Drugs & Therapeutics for Cytomegalovirus Retinitis

Drugs for Cytomegalovirus Retinitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 115)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ganciclovir Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 82410-32-0 3454
2
Cidofovir Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 113852-37-2 60613
3
Foscarnet Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 63585-09-1, 4428-95-9 3415
4
Probenecid Approved, Investigational Phase 4,Phase 2,Phase 1,Not Applicable 57-66-9 4911
5
Phosphonoacetic Acid Experimental Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 4408-78-0 546
6 Antiviral Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
7 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
8 Ganciclovir triphosphate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
9 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
10 Anti-Retroviral Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
11 Reverse Transcriptase Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
12 Antirheumatic Agents Phase 4,Phase 2,Phase 1,Not Applicable
13 Renal Agents Phase 4,Phase 2,Phase 1,Not Applicable
14
Valganciclovir Approved, Investigational Phase 3,Not Applicable 175865-60-8 64147
15
Sargramostim Approved, Investigational Phase 3,Not Applicable 123774-72-1, 83869-56-1
16
Acyclovir Approved Phase 3,Not Applicable 59277-89-3 2022
17 Antibodies Phase 2, Phase 3,Phase 1,Not Applicable
18 Immunologic Factors Phase 2, Phase 3,Phase 3,Phase 1,Not Applicable
19 Antibodies, Monoclonal Phase 2, Phase 3,Phase 1
20 Antineoplastic Agents, Immunological Phase 2, Phase 3
21 Immunoglobulins Phase 2, Phase 3,Phase 1,Not Applicable
22
Nelfinavir Approved Phase 2 159989-64-7 64143
23 HIV Protease Inhibitors Phase 2
24
protease inhibitors Phase 2
25 Anti-HIV Agents Phase 2,Phase 1,Not Applicable
26
Aldesleukin Approved Phase 1 85898-30-2, 110942-02-4
27 Peripheral Nervous System Agents Phase 1
28 Analgesics Phase 1
29 Analgesics, Non-Narcotic Phase 1
30 Interleukin-2 Phase 1
31
Zidovudine Approved Not Applicable 30516-87-1 35370
32
Interferon beta-1b Approved Not Applicable 145155-23-3
33
Fosphenytoin Approved, Investigational 93390-81-9 56339
34
Methylprednisolone hemisuccinate Approved 2921-57-5
35
Midazolam Approved, Illicit 59467-70-8 4192
36
Alfentanil Approved, Illicit 71195-58-9 51263
37
Tazobactam Approved 89786-04-9 123630
38
Lidocaine Approved, Vet_approved 137-58-6 3676
39
Methylprednisolone Approved, Vet_approved 83-43-2 6741
40
Pentobarbital Approved, Investigational, Vet_approved 76-74-4 4737
41
Vancomycin Approved 1404-90-6 441141 14969
42
Diazepam Approved, Illicit, Investigational, Vet_approved 439-14-5 3016
43
Molindone Approved 7416-34-4 23897
44
Nafcillin Approved, Investigational 985-16-0, 147-52-4 8982
45
Haloperidol Approved 52-86-8 3559
46
Prednisolone Approved, Vet_approved 50-24-8 5755
47
Cefepime Approved, Investigational 88040-23-7 5479537
48
Prednisolone phosphate Approved, Vet_approved 302-25-0
49
Ceftazidime Approved 78439-06-2, 72558-82-8 5481173
50
Dexmedetomidine Approved, Vet_approved 113775-47-6 68602 5311068

Interventional clinical trials:

(show top 50) (show all 68)
# Name Status NCT ID Phase Drugs
1 Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV Retinitis Completed NCT00000894 Phase 4 Cidofovir;Probenecid;Ganciclovir
2 A Multicenter Study of Oral Versus Intravenous Hydration in AIDS Patients With CMV Retinitis Treated With Foscavir (Foscarnet Sodium) Completed NCT00002125 Phase 4 Foscarnet sodium
3 Pharmacokinetics of Cidofovir During Continuous Venovenous Hemofiltration Completed NCT01866397 Phase 4
4 Use of Cidofovir for Recurrent Respiratory Papillomatosis Completed NCT00205374 Phase 4 Cidofovir;Placebo
5 Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection Unknown status NCT00017784 Phase 3 Valganciclovir
6 A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS Completed NCT00000688 Phase 3 Ganciclovir
7 Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT) Completed NCT00000134 Phase 3 Ganciclovir;Foscarnet
8 Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT) Completed NCT00000135 Phase 2, Phase 3 MSL-109
9 A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis Completed NCT00000698 Phase 3 Ganciclovir
10 Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT) Completed NCT00000143 Phase 3 Cidofovir intravenous
11 Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT) Completed NCT00000136 Phase 3 Foscarnet;Ganciclovir
12 Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis Completed NCT00002070 Phase 3 Sargramostim;Ganciclovir
13 Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT) Completed NCT00000142 Phase 2, Phase 3 Cidofovir
14 Ganciclovir Implant Study for Cytomegalovirus Retinitis Completed NCT00000118 Phase 3
15 A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes Completed NCT00002377 Phase 3 Valganciclovir;Ganciclovir
16 Valganciclovir in Prevention of Cytomegalovirus (CMV) Reactivation Following Allogeneic-Stem Cell Transplantation (SCT) Completed NCT00330018 Phase 3 Valganciclovir;Acyclovir
17 A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR ) Completed NCT00002156 Phase 2 Fomivirsen sodium;Ganciclovir
18 Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis Completed NCT00004794 Phase 2 cidofovir
19 A Phase II Dose-Ranging, Open-Labelled Trial of Foscarnet Salvage Therapy for AIDS Patients With Sight-Threatening CMV Retinitis Who Cannot Be Treated With Ganciclovir Due To Myelosuppression or Treatment Failure Completed NCT00000691 Phase 2 Foscarnet sodium
20 CMV Retinitis Retreatment Trial Completed NCT00000766 Phase 2 Foscarnet sodium;Ganciclovir
21 The Safety and Effectiveness of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Completed NCT00002437 Phase 2 Cidofovir;Probenecid
22 The Safety and Effectiveness of ISIS 2922 in Patients With AIDS Who Have Cytomegalovirus (CMV) of the Eyes Completed NCT00002356 Phase 2 Fomivirsen sodium
23 A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis Completed NCT00002169 Phase 2 Nelfinavir mesylate
24 A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Cannot Use Ganciclovir Withdrawn NCT00000697 Phase 2 Foscarnet sodium
25 A Phase II/III Trial of Human Anti-CMV Monoclonal Antibody MSL 109 (MACRT) Completed NCT00000836 Phase 2 Sevirumab
26 Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS Completed NCT00001061 Phase 2 Sevirumab;Foscarnet sodium;Ganciclovir
27 The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV Completed NCT00001034 Phase 2 Ganciclovir
28 A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy Completed NCT00000673 Phase 1 Ganciclovir
29 A Phase I/II Trial to Assess the Safety and Tolerance of Escalating Doses of a Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Retinitis Completed NCT00002016 Phase 1 Sevirumab
30 Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome Completed NCT00000726 Phase 1 Foscarnet sodium
31 A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes Completed NCT00001062 Phase 1 Ganciclovir
32 A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With Ganciclovir Completed NCT00000970 Phase 1 Foscarnet sodium;Ganciclovir
33 A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis Completed NCT00002321 Phase 1 Aldesleukin
34 A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral Ganciclovir Completed NCT00000668 Phase 1 Ganciclovir
35 A Study of Cidofovir in HIV-Infected Children With Cytomegalovirus (CMV) Disease Withdrawn NCT00000881 Phase 1 Cidofovir;Probenecid
36 A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease Completed NCT00000805 Phase 1 Ganciclovir
37 A Study of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Unknown status NCT00002384 Not Applicable Cidofovir
38 A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Have Not Had Success With Ganciclovir Unknown status NCT00002301 Not Applicable Foscarnet sodium
39 Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS Completed NCT00000693 Not Applicable Zidovudine;Acyclovir
40 A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS Completed NCT00002257 Not Applicable Ganciclovir
41 A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis Completed NCT00002134 Not Applicable Ganciclovir
42 A Study of the Safety and Tolerance of Long-Term Therapy With Intravenous Cytovene (Ganciclovir Sodium) for Cytomegalovirus Retinitis in Persons With AIDS Completed NCT00002034 Not Applicable Zidovudine;Ganciclovir
43 A Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir Therapy Completed NCT00002247 Not Applicable Ganciclovir
44 A Study of ISIS 2922 in the Treatment of Advanced Cytomegalovirus Retinitis Completed NCT00002187 Not Applicable Fomivirsen sodium
45 An Open-Label Study of the Safety and Efficacy of Cidofovir for the Treatment of Relapsing Cytomegalovirus Retinitis in Patients With AIDS Completed NCT00002142 Not Applicable Cidofovir;Probenecid
46 Efficacy of Elevated CD4 Counts on CMV Retinitis Completed NCT00091884
47 Studies of the Ocular Complications of AIDS (SOCA) CMV Retinitis Trial: Foscarnet-Ganciclovir Component Completed NCT00000665 Not Applicable Foscarnet sodium;Ganciclovir
48 A Study of Valganciclovir in the Treatment of Cytomegalovirus (CMV) Retinitis in Patients With AIDS Completed NCT00002222 Not Applicable Valganciclovir
49 HPMPC (Cidofovir) Peripheral CMV Retinitis Trial Protocol Completed NCT00000799 Not Applicable Cidofovir;Probenecid
50 An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous Access Completed NCT00002135 Not Applicable Ganciclovir

Search NIH Clinical Center for Cytomegalovirus Retinitis

Inferred drug relations via UMLS 74 / NDF-RT 52 :


Cochrane evidence based reviews: cytomegalovirus retinitis

Genetic Tests for Cytomegalovirus Retinitis

Anatomical Context for Cytomegalovirus Retinitis

MalaCards organs/tissues related to Cytomegalovirus Retinitis:

42
Eye, Retina, T Cells, Bone, Bone Marrow, Testes, Endothelial

Publications for Cytomegalovirus Retinitis

Articles related to Cytomegalovirus Retinitis:

(show top 50) (show all 1054)
# Title Authors Year
1
CD4+ cells as a potential biomarker for cytomegalovirus retinitis in children with acute lymphocytic leukemia. ( 30681505 )
2019
2
Active cytomegalovirus retinitis after the start of antiretroviral therapy. ( 30196272 )
2019
3
Use of Letermovir as Salvage Therapy for Drug-Resistant Cytomegalovirus Retinitis. ( 30642941 )
2019
4
A cross-sectional study of cytomegalovirus retinitis in HIV-1 infected adults in Nigeria. ( 30837414 )
2019
5
Concurrent cerebral toxoplasmosis and cytomegalovirus retinitis in a patient with human immunodeficiency virus. ( 30851795 )
2019
6
Spectral domain optical coherence tomography and fundus autofluorescence findings in cytomegalovirus retinitis in HIV-infected patients. ( 29445945 )
2018
7
Cytomegalovirus retinitis before and after treatment. ( 29776766 )
2018
8
Acute Progressive Visual Loss in a Case of Acute Myeloid Leukemia: Challenges in the Utility of Molecular Tests in Early Diagnose of Cytomegalovirus Retinitis. ( 29560000 )
2018
9
Suppressor of Cytokine Signaling (SOCS)1 and SOCS3 Are Stimulated Within the Eye During Experimental Murine Cytomegalovirus Retinitis in Mice With Retrovirus-Induced Immunosuppression. ( 29976680 )
2018
10
RAPIDLY PROGRESSIVE NEOVASCULAR GLAUCOMA FROM CYTOMEGALOVIRUS RETINITIS IN A NON-HUMAN IMMUNODEFICIENCY VIRUS PATIENT. ( 29533389 )
2018
11
Cytomegalovirus retinitis, in a diabetic immunocompetent patient, after intravitreal ranibizumab injection. ( 29747535 )
2018
12
Synthesis, physicochemical properties and ocular pharmacokinetics of thermosensitive in situ hydrogels for ganciclovir in cytomegalovirus retinitis treatment. ( 29228826 )
2018
13
Visual acuity outcomes in cytomegalovirus retinitis: early versus late diagnosis. ( 30206157 )
2018
14
HLA-C Alleles and Cytomegalovirus Retinitis in Brazilian Patients with AIDS. ( 30245869 )
2018
15
Ocular Ischemic Syndrome as the Initial Presenting Feature of Cytomegalovirus Retinitis. ( 30311468 )
2018
16
Cytomegalovirus Retinitis in Primary Immune Deficiency Disease. ( 30327738 )
2018
17
Comparison of intravitreal ganciclovir monotherapy and combination with foscarnet as initial therapy for cytomegalovirus retinitis. ( 30364196 )
2018
18
Spectrum of Newly Diagnosed Cytomegalovirus Retinitis in a Developing Country in the HAART Era. ( 30395753 )
2018
19
Initial intravitreal injection of high-dose ganciclovir for cytomegalovirus retinitis in HIV-negative patients. ( 30526535 )
2018
20
Successively bilateral cytomegalovirus retinitis in immunocompromised patient with Good's syndrome. ( 30588440 )
2018
21
Cytomegalovirus retinitis in the post-cART era. ( 30886765 )
2018
22
Macular oedema due to immune reconstitution uveitis occurring in an HIV-negative patient without cytomegalovirus retinitis. ( 30009623 )
2018
23
Visual prognosis, clinical features, and predisposing factors in non-HIV patients with cytomegalovirus retinitis. ( 30030661 )
2018
24
Ganciclovir-Induced Bullae Formation Secondary to Extravasation in a Patient Being Treated for Cytomegalovirus Retinitis. ( 30039977 )
2018
25
Macular cytomegalovirus retinitis following dexamethasone intravitreal implant combined with phacoemulsification. ( 30127173 )
2018
26
Aqueous cytomegalovirus DNA and interleukin-8 determination in management of cytomegalovirus retinitis. ( 30187638 )
2018
27
COMPARISON OF VISUAL PROGNOSIS AND CLINICAL FEATURES OF CYTOMEGALOVIRUS RETINITIS IN HIV AND NON-HIV PATIENTS. ( 28118285 )
2017
28
Cytomegalovirus retinitis in a patient with secondary acute lymphosarcoma leukemia undergoing allogeneic hematopoietic stem-cell transplantation: A rare case report: a care-compliant article. ( 28489788 )
2017
29
Cytomegalovirus Retinitis: A Review. ( 28355091 )
2017
30
Cytomegalovirus Retinitis as a Presenting Feature of Multisystem Disorder: Dyskeratosis Congenita. ( 29422759 )
2017
31
Bilateral retinal detachment associated with cytomegalovirus retinitis. ( 29054478 )
2017
32
CYTOMEGALOVIRUS RETINITIS ASSOCIATED WITH OCCLUSIVE VASCULOPATHY IN AN ELDERLY, HUMAN IMMUNODEFICIENCY VIRUS-NEGATIVE MAN. ( 28937523 )
2017
33
Cytomegalovirus retinitis followed by immune recovery uveitis in an elderly patient with rheumatoid arthritis undergoing administration of methotrexate and tofacitinib combination therapy. ( 28389165 )
2017
34
Bilateral cytomegalovirus retinitis in a healthy infant. ( 28367531 )
2017
35
Incidence Rates and Risk Factors for Vision Loss among AIDS-Related Cytomegalovirus Retinitis Patients in Southern Thailand. ( 28323489 )
2017
36
Cytomegalovirus retinitis in relapsed or refractory low-grade B cell lymphoma patients treated with bendamustine. ( 28447162 )
2017
37
Cytomegalovirus Retinitis in Patients With Acquired Immunodeficiency Syndrome After Initiating Antiretroviral Therapy. ( 27984023 )
2017
38
Cytomegalovirus retinitis and HIV: Case reviews from KwaZulu-Natal Province, South Africa. ( 29022526 )
2017
39
Cytomegalovirus retinitis in Cape Town, South Africa: Clinical management and outcomes. ( 28604324 )
2017
40
OPTICAL COHERENCE TOMOGRAPHY FINDINGS IN CYTOMEGALOVIRUS RETINITIS: A Longitudinal Study. ( 28145973 )
2017
41
Treatment of unilateral zone I cytomegalovirus retinitis in acute lymphoblastic leukemia with oral valganciclovir and intravitreal ganciclovir. ( 29118508 )
2017
42
Comparative analysis of cytomegalovirus retinitis and microvascular retinopathy in patients with acquired immunodeficiency syndrome. ( 28944199 )
2017
43
SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY FINDINGS IN MACULA-INVOLVING CYTOMEGALOVIRUS RETINITIS. ( 28376042 )
2017
44
Cytomegalovirus Retinitis in Immunocompetent Young Male. ( 28969754 )
2017
45
Cytomegalovirus retinitis in HIV-negative patients - associated conditions, clinical presentation, diagnostic methods and treatment strategy. ( 29068151 )
2017
46
Reduced frequency of murine cytomegalovirus retinitis in C57BL/6 mice correlates with low levels of suppressor of cytokine signaling (SOCS)1 and SOCS3 expression within the eye during corticosteroid-induced immunosuppression. ( 28558309 )
2017
47
Cytokine Profiles in Aqueous Humor and Plasma of HIV-infected Individuals with Ocular Syphilis or Cytomegalovirus Retinitis. ( 28081374 )
2017
48
High ocular CMV copies and mismatched receipts may predict poor visual prognosis in CMV retinitis patients following allogeneic haematopoietic stem cell transplantation. ( 29187167 )
2017
49
Cytomegalovirus Retinitis as the First Manifestation of Good Syndrome. ( 27715373 )
2016
50
Cytomegalovirus retinitis in an immunocompetent patient: A case report. ( 27331155 )
2016

Variations for Cytomegalovirus Retinitis

Expression for Cytomegalovirus Retinitis

Search GEO for disease gene expression data for Cytomegalovirus Retinitis.

Pathways for Cytomegalovirus Retinitis

GO Terms for Cytomegalovirus Retinitis

Sources for Cytomegalovirus Retinitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....